SAN ANTONIO--(BUSINESS WIRE)--$BIAF #BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive ...
News
- New Case Study: bioAffinity Technologies' CyPath® Lung Provides Actionable Results and ...
- Bicycle Therapeutics cuts 30% of workforce as it winds down lead cancer drug - Boston ...
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... The biotech discontinued two Phase 1/2 trials of its lead cancer drug ...
- New Case Study: bioAffinity Technologies' CyPath® Lung Provides Actionable Results and ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for ...
- Lenoss Medical Announces Successful Close of $6 Million Growth Bridge Financing
PROVIDENCE, GA, UNITED STATES, March 17, 2026 /EINPresswire.com/ — Lenoss Medical, a biomedical ... San Antonio This April. SAN ANTONIO, TX, UNITED ...
- Engineering team deliberates on ethics during case competition - The Paisano
Despite UT San Antonio not participating in the competition for the past six years, junior biomedical engineering major Christian Unogu, senior ...